Camingao, Ricky P.
HRN: 23-64-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/31/2023
09/07/2023
IV
500mg
Q8hour
Liver Parenchymal Disease
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes